By 2021, the AI healthcare market will grow from $600 million to over $6 billion
according to Frost & Sullivan
Bold Brain Ventures will invest in early stage Artificial Intelligence companies that have a primary focus on developing solutions in radiology. The managing partners will invest in multiple Radiology AI companies to create diversified access to this sector.
Capital deployment will likely occur in 1-3 years. Startup company exits will likely be via acquisition by larger companies, which will typically occur over 3-7 years. The fund expects to conclude in year 10.
A small percentage of the exiting companies will likely result in most of the financial gain. Therefore, management believes that investing in a diversified portfolio is more likely to yield profitable outcomes and be less risky than investing in a single venture. Bold Brain Ventures is targeting a $25MM fund size with approximately 20 investments.
This is a long-term investment. While near term profits are unlikely, longer term potential returns may be considerable.
Bold Brain Ventures is not constrained by geography. The Fund plans to invest in companies with both U.S. and international locations. There are numerous AI startups working on healthcare solutions worldwide. Many of these companies show enormous potential and are still in the initial stages of raising funds, giving Bold Brain Ventures an opportunity to invest early.
The radiology-centric approach of Bold Brain Ventures makes for a unique investment opportunity. Many companies have already expressed interest in having radiologists as investors. Because startups want radiologist input as they develop their solutions, Bold Brain Ventures has a considerable advantage over conventional Venture Capital approaches to investing.
Terms of the offering
First Close: $1,000,000
Minimum Subscription: $25,000 (25,000 Units)
The Company is offering a minimum of 1,000,000 and a maximum of 100,000,000 Limited Partnership Units at a price of $1.00 per Unit.
Regulation D 506(c) Mandated Legend
Any historical performance data represents past performance. Past performance does not guarantee future results; Current performance may be different than the performance data presented; The Company is not required by law to follow any standard methodology
when calculating and representing performance data; The performance of the Company may not be directly comparable to the performance of other private or registered funds or companies; The securities are being offered in reliance on an exemption from
the registration requirements, and therefore are not required to comply with certain specific disclosure requirements; The Securities and Exchange Commission has not passed upon the merits of or approved the securities, the terms of the offering, or
the accuracy of the materials.